Dendrimer-based RNA interference delivery for cancer therapy

ACS Symposium Series

Volumn 1135, Issue , 2013, Pages 197-213

  Xu, Leyuan ^a   Andrew Yeudall, W ^b,c   Yang, Hu ^a,c  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMERS; DISEASES; MEDICAL APPLICATIONS; RNA;

CANCER THERAPY; RNA INTERFERENCE;

FUNCTIONAL POLYMERS;

EID: 84905397389     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2013-1135.ch012     Document Type: Conference Paper

References (57)

1. Fire, A.; Xu, S.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-11.
2. Pecot, C. V.; Calin, G. A.; Coleman, R. L.; Lopez-Berestein, G.; Sood, A. K. RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 2011, 11, 59-67.
3. Kawamata, T.; Tomari, Y. Making RISC. Trends Biochem. Sci. 2010, 35, 368-76.
4. Petrocca, F.; Lieberman, J. Promise and challenge of RNA interference-based therapy for cancer. J. Clin. Oncol. 2011, 29, 747-754.
5. Kolch, W.; Pitt, A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat. Rev. Cancer 2010, 10, 618-29.
6. Prenzel, N.; Fischer, O. M.; Streit, S.; Hart, S.; Ullrich, A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr.-Relat. Cancer 2001, 8, 11-31.
7. Yuan, Q.; Lee, E.; Yeudall, W. A.; Yang, H. Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery. Oral Oncol. 2010, 46, 698-704.
8. Wang, H.; Teh, M. T.; Ji, Y.; Patel, V.; Firouzabadian, S.; Patel, A. A.; Gutkind, J. S.; Yeudall, W. A. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Carcinogenesis 2010, 31, 1132-1141.
9. Wang, H.; Patel, V.; Miyazaki, H.; Gutkind, J. S.; Yeudall, W. A. Role for EPS8 in squamous carcinogenesis. Carcinogenesis 2009, 30, 165-74.
10. Oh, Y. K.; Park, T. G. siRNA delivery systems for cancer treatment. Adv. Drug Delivery Rev. 2009, 61, 850-862.
11. Davis, M. E. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol. Pharm. 2009, 6, 659-68.
12. Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464, 1067-1070.
13. Senzer, N.; Barve, M.; Kuhn, J.; Melnyk, A.; Beitsch, P.; Lazar, M.; Lifshitz, S.; Magee, M.; Oh, J.; Mill, S. W.; Bedell, C.; Higgs, C.; Kumar, P.; Yu, Y.; Norvell, F.; Phalon, C.; Taquet, N.; Rao, D. D.; Wang, Z.; Jay, C. M.; Pappen, B. O.; Wallraven, G.; Brunicardi, F. C.; Shanahan, D. M.; Maples, P. B.; Nemunaitis, J. Phase I trial of bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell vaccine (FANG) in advanced cancer. Mol. Ther. 2012, 20, 679-686.
14. Yano, J.; Hirabayashi, K.; Nakagawa, S.; Yamaguchi, T.; Nogawa, M.; Kashimori, I.; Naito, H.; Kitagawa, H.; Ishiyama, K.; Ohgi, T.; Irimura, T. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin. Cancer Res. 2004, 10, 7721-7726.
15. Bisanz, K.; Yu, J.; Edlund, M.; Spohn, B.; Hung, M. C.; Chung, L. W.; Hsieh, C. L. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. Mol. Ther. 2005, 12, 634-643.
16. Santel, A.; Aleku, M.; Keil, O.; Endruschat, J.; Esche, V.; Durieux, B.; Loffler, K.; Fechtner, M.; Rohl, T.; Fisch, G.; Dames, S.; Arnold, W.; Giese, K.; Klippel, A.; Kaufmann, J. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther. 2006, 13, 1360-70.
17. Pal, A.; Ahmad, A.; Khan, S.; Sakabe, I.; Zhang, C.; Kasid, U. N.; Ahmad, I. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. Int. J. Oncol. 2005, 26, 1087-1091.
18. Chien, P. Y.; Wang, J.; Carbonaro, D.; Lei, S.; Miller, B.; Sheikh, S.; Ali, S. M.; Ahmad, M. U.; Ahmad, I. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 2005, 12, 321-328.
19. Yamato, K.; Yamada, T.; Kizaki, M.; Ui-Tei, K.; Natori, Y.; Fujino, M.; Nishihara, T.; Ikeda, Y.; Nasu, Y.; Saigo, K.; Yoshinouchi, M. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther. 2008, 15, 140-153.
20. Hogrefe, R. I.; Lebedev, A. V.; Zon, G.; Pirollo, K. F.; Rait, A.; Zhou, Q.; Yu, W.; Chang, E. H. Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2. Nucleosides, Nucleotides Nucleic Acids 2006, 25, 889-907.
21. Landen, C. N., Jr.; Chavez-Reyes, A.; Bucana, C.; Schmandt, R.; Deavers, M. T.; Lopez-Berestein, G.; Sood, A. K. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 2005, 65, 6910-8.
22. Landen, C. N.; Merritt, W. M.; Mangala, L. S.; Sanguino, A. M.; Bucana, C.; Lu, C.; Lin, Y. G.; Han, L. Y.; Kamat, A. A.; Schmandt, R.; Coleman, R. L.; Gershenson, D. M.; Lopez-Berestein, G.; Sood, A. K. Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. Cancer Biol. Ther. 2006, 5, 1708-1713.
23. Halder, J.; Kamat, A. A.; Landen, C. N., Jr.; Han, L. Y.; Lutgendorf, S. K.; Lin, Y. G.; Merritt, W. M.; Jennings, N. B.; Chavez-Reyes, A.; Coleman, R. L.; Gershenson, D. M.; Schmandt, R.; Cole, S. W.; Lopez-Berestein, G.; Sood, A. K. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. 2006, 12, 4916-4924.
24. Thaker, P. H.; Han, L. Y.; Kamat, A. A.; Arevalo, J. M.; Takahashi, R.; Lu, C.; Jennings, N. B.; Armaiz-Pena, G.; Bankson, J. A.; Ravoori, M.; Merritt, W. M.; Lin, Y. G.; Mangala, L. S.; Kim, T. J.; Coleman, R. L.; Landen, C. N.; Li, Y.; Felix, E.; Sanguino, A. M.; Newman, R. A.; Lloyd, M.; Gershenson, D. M.; Kundra, V.; Lopez-Berestein, G.; Lutgendorf, S. K.; Cole, S. W.; Sood, A. K. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 2006, 12, 939-944.
25. Merritt, W. M.; Lin, Y. G.; Spannuth, W. A.; Fletcher, M. S.; Kamat, A. A.; Han, L. Y.; Landen, C. N.; Jennings, N.; De, G. K.; Langley, R. R.; Villares, G.; Sanguino, A.; Lutgendorf, S. K.; Lopez-Berestein, G.; Bar-Eli, M. M.; Sood, A. K. Effect of interleukin-8 gene silencing with liposomeencapsulated small interfering RNA on ovarian cancer cell growth. J. Natl. Cancer Inst. 2008, 100, 359-372.
26. Urban-Klein, B.; Werth, S.; Abuharbeid, S.; Czubayko, F.; Aigner, A. RNAimediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 2005, 12, 461-6.
27. Ma, Z.; Li, J.; He, F.; Wilson, A.; Pitt, B.; Li, S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 2005, 330, 755-759.
28. Xu, C. X.; Jere, D.; Jin, H.; Chang, S. H.; Chung, Y. S.; Shin, J. Y.; Kim, J. E.; Park, S. J.; Lee, Y. H.; Chae, C. H.; Lee, K. H.; Beck, G. R., Jr.; Cho, C. S.; Cho, M. H. Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am. J. Respir. Crit. Care Med. 2008, 178, 60-73.
29. Zhang, Z.; Yang, X.; Zhang, Y.; Zeng, B.; Wang, S.; Zhu, T.; Roden, R. B.; Chen, Y.; Yang, R. Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin. Cancer Res. 2006, 12, 4933-4939.
30. He, X. W.; Liu, T.; Chen, Y. X.; Cheng, D. J.; Li, X. R.; Xiao, Y.; Feng, Y. L. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. Cancer Gene Ther. 2008, 15, 193-202.
31. Yoshizawa, T.; Hattori, Y.; Hakoshima, M.; Koga, K.; Maitani, Y. Folatelinked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur. J. Pharm. Biopharm. 2008, 70, 718-725.
32. Grzelinski, M.; Urban-Klein, B.; Martens, T.; Lamszus, K.; Bakowsky, U.; Hobel, S.; Czubayko, F.; Aigner, A. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 2006, 17, 751-766.
33. Fujii, T.; Saito, M.; Iwasaki, E.; Ochiya, T.; Takei, Y.; Hayashi, S.; Ono, A.; Hirao, N.; Nakamura, M.; Kubushiro, K.; Tsukazaki, K.; Aoki, D. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer. Int. J. Oncol. 2006, 29, 541-548.
34. Hu-Lieskovan, S.; Heidel, J. D.; Bartlett, D. W.; Davis, M. E.; Triche, T. J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewings sarcoma. Cancer Res. 2005, 65, 8984-8992.
35. Song, E.; Zhu, P.; Lee, S. K.; Chowdhury, D.; Kussman, S.; Dykxhoorn, D. M.; Feng, Y.; Palliser, D.; Weiner, D. B.; Shankar, P.; Marasco, W. A.; Lieberman, J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 2005, 23, 709-17.
36. Golzio, M.; Mazzolini, L.; Ledoux, A.; Paganin, A.; Izard, M.; Hellaudais, L.; Bieth, A.; Pillaire, M. J.; Cazaux, C.; Hoffmann, J. S.; Couderc, B.; Teissie, J. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther. 2007, 14, 752-759.
37. Jackson, A. L.; Linsley, P. S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat. Rev. Drug Discovery 2010, 9, 57-67.
38. Rao, D. D.; Vorhies, J. S.; Senzer, N.; Nemunaitis, J. siRNA vs. shRNA: similarities and differences. Adv. Drug Delivery Rev. 2009, 61, 746-759.
39. Lim, Y. B.; Kim, S. M.; Suh, H.; Park, J. S. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjugate Chem. 2002, 13, 952-7.
40. Mahato, R. I.; Henry, J.; Narang, A. S.; Sabek, O.; Fraga, D.; Kotb, M.; Gaber, A. O. Cationic lipid and polymer-based gene delivery to human pancreatic islets. Mol. Ther. 2003, 7, 89-100.
41. De Smedt, S. C.; Demeester, J.; Hennink, W. E. Cationic polymer based gene delivery systems. Pharm. Res. 2000, 17, 113-26.
42. Pack, D. W.; Hoffman, A. S.; Pun, S.; Stayton, P. S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discovery 2005, 4, 581-93.
43. Luo, D.; Saltzman, W. M. Synthetic DNA delivery systems. Nat. Biotechnol. 2000, 18, 33-37.
44. Remy-Kristensen, A.; Clamme, J. P.; Vuilleumier, C.; Kuhry, J. G.; Mely, Y. Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes. Biochim. Biophys. Acta 2001, 1514, 21-32.
45. Liu, M.; Frechet, J. M. J. Designing dendrimers for drug delivery. Pharm. Sci. Technol. Today 1999, 2, 393-401.
46. Esfand, R.; Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discovery Today 2001, 6, 427-436.
47. Newkome, G. R.; Yao, Z.; Baker, G. R.; Gupta, V. K. Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol. J. Org. Chem. 1985, 50, 2003-4.
48. Svenson, S.; Tomalia, D. A. Dendrimers in biomedical applications- reflections on the field. Adv. Drug Delivery Rev. 2005, 57, 2106-29.
49. Yang, H.; Kao, W. J. Dendrimers for pharmaceutical and biomedical applications. J. Biomater. Sci., Polym. Ed. 2006, 17, 3-19.
50. Eichman, J. D.; Bielinska, A. U.; Kukowska-Latallo, J. F.; Baker, J. R., Jr. The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technol. Today 2000, 3, 232-245.
51. Bielinska, A. U.; Yen, A.; Wu, H. L.; Zahos, K. M.; Sun, R.; Weiner, N. D.; Baker, J. R., Jr.; Roessler, B. J. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials 2000, 21, 877-887.
52. Schatzlein, A. G.; Zinselmeyer, B. H.; Elouzi, A.; Dufes, C.; Chim, Y. T. A.; Roberts, C. J.; Davies, M. C.; Munro, A.; Gray, A. I.; Uchegbu, I. F. Preferential liver gene expression with polypropylenimine dendrimers. J. Controlled Release 2005, 101, 247-258.
53. Takahashi, T.; Harada, A.; Emi, N.; Kono, K. Preparation of efficient gene carriers using a polyamidoamine dendron-bearing lipid: improvement of serum resistance. Bioconjugate Chem. 2005, 16, 1160-1165.
54. Sonawane, N. D.; Szoka, F. C., Jr.; Verkman, A. S. Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes. J. Biol. Chem. 2003, 278, 44826-44831.
55. Tang, Y.; Li, Y. B.; Wang, B.; Lin, R. Y.; van, D. M.; Zurcher, D. M.; Gu, X. Y.; Banaszak Holl, M. M.; Liu, G.; Qi, R. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol. Pharm. 2012, 9, 1812-1821.
56. Yuan, Q.; Yeudall, W. A.; Yang, H. PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery. Biomacromolecules 2010, 11, 1940-7.
57. Agrawal, A.; Min, D. H.; Singh, N.; Zhu, H.; Birjiniuk, A.; von Maltzahn, G.; Harris, T. J.; Xing, D.; Woolfenden, S. D.; Sharp, P. A.; Charest, A.; Bhatia, S. Functional delivery of siRNA in mice using dendriworms. ACS Nano 2009, 3, 2495-504.